Practice question

Answer the question and get instant feedback.

Hard"KDIGO recommends SGLT2 inhibitor in T2D with CKD and eGFR ≥20 to reduce CKD and CV outcomesKDIGO Guideline (2022): Diabetes Management in CKD"nephrology"

A 63-year-old with type 2 diabetes and albuminuria (UACR 220 mg/g) is on maximally tolerated ACE inhibitor. Next step to slow CKD progression and reduce CV risk?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.